An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

In principle, almost all cells in the body have an identical genome ). But how is it possible then that such different and highly specialized cell types ... on the liver cancer model showed ...

YIV-906 has been observed to enhance the anti-tumor activity of sorafenib in preclinical models of hepatocellular ... It holds promise for the treatment of all types of liver cancer, offering ...

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer ... help us better understand liver cancer in Mexico and improve prevention, detection, and treatment strategies," he said.

In principle, almost all cells in the body have an identical genome. But how is it possible then that such different and highly specialized cell types ... on the liver cancer model showed that ...